BR9907912A - Composição, processos para tratar câncer, para eliciar linfócitos t que se infiltram em um tumor de um mamìfero, para eliciar uma resposta de hipersensibilidade do tipo retardo a um tumor de um mamìfero, e para preparar membranas de células tumorais modificadas com hapteno, e, membrana isolada de célula tumoral de mamìfero - Google Patents
Composição, processos para tratar câncer, para eliciar linfócitos t que se infiltram em um tumor de um mamìfero, para eliciar uma resposta de hipersensibilidade do tipo retardo a um tumor de um mamìfero, e para preparar membranas de células tumorais modificadas com hapteno, e, membrana isolada de célula tumoral de mamìferoInfo
- Publication number
- BR9907912A BR9907912A BR9907912-7A BR9907912A BR9907912A BR 9907912 A BR9907912 A BR 9907912A BR 9907912 A BR9907912 A BR 9907912A BR 9907912 A BR9907912 A BR 9907912A
- Authority
- BR
- Brazil
- Prior art keywords
- tumor cell
- elicit
- tumor
- processes
- mammalian
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 11
- 239000012528 membrane Substances 0.000 title abstract 11
- 210000004881 tumor cell Anatomy 0.000 title abstract 10
- 239000000203 mixture Substances 0.000 title abstract 8
- 238000000034 method Methods 0.000 title abstract 7
- 201000011510 cancer Diseases 0.000 title abstract 5
- 210000001744 T-lymphocyte Anatomy 0.000 title abstract 4
- 230000005951 type IV hypersensitivity Effects 0.000 title 1
- 230000002757 inflammatory effect Effects 0.000 abstract 2
- 241000124008 Mammalia Species 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 230000003111 delayed effect Effects 0.000 abstract 1
- 239000002552 dosage form Substances 0.000 abstract 1
- 230000009610 hypersensitivity Effects 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 208000027930 type IV hypersensitivity disease Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/001102—Receptors, cell surface antigens or cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6012—Haptens, e.g. di- or trinitrophenyl (DNP, TNP)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Oncology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2501298A | 1998-02-17 | 1998-02-17 | |
| PCT/US1999/003536 WO1999040925A2 (en) | 1998-02-17 | 1999-02-17 | Hapten-modified tumor cell membranes and their use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9907912A true BR9907912A (pt) | 2000-10-24 |
Family
ID=21823570
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9907912-7A BR9907912A (pt) | 1998-02-17 | 1999-02-17 | Composição, processos para tratar câncer, para eliciar linfócitos t que se infiltram em um tumor de um mamìfero, para eliciar uma resposta de hipersensibilidade do tipo retardo a um tumor de um mamìfero, e para preparar membranas de células tumorais modificadas com hapteno, e, membrana isolada de célula tumoral de mamìfero |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP1054690A2 (ko) |
| JP (1) | JP2002502880A (ko) |
| KR (1) | KR20010041018A (ko) |
| CN (1) | CN1291105A (ko) |
| AR (1) | AR015237A1 (ko) |
| AU (1) | AU2686999A (ko) |
| BR (1) | BR9907912A (ko) |
| CA (1) | CA2320969A1 (ko) |
| IL (1) | IL137791A0 (ko) |
| PL (1) | PL342856A1 (ko) |
| WO (1) | WO1999040925A2 (ko) |
| ZA (1) | ZA991245B (ko) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003524583A (ja) * | 1998-04-09 | 2003-08-19 | トーマス・ジェファーソン・ユニバーシティ | 黒色腫患者における肺転移に対して抗腫瘍応答を誘導する方法 |
| US6248585B1 (en) | 1998-11-19 | 2001-06-19 | Thomas Jefferson University | Compositions for preserving haptenized tumor cells for use in vaccines |
| US7297330B2 (en) | 2000-02-04 | 2007-11-20 | Thomas Jefferson University | Low dose haptenized tumor cell and tumor cell extract immunotherapy |
| JP2004507446A (ja) * | 2000-02-04 | 2004-03-11 | トーマス・ジェファーソン・ユニバーシティ | 低用量ハプテン化腫瘍細胞および腫瘍細胞抽出物の免疫治療 |
| US7612251B2 (en) | 2000-09-26 | 2009-11-03 | Pioneer Hi-Bred International, Inc. | Nucleotide sequences mediating male fertility and method of using same |
| AU2003243485A1 (en) * | 2002-06-10 | 2003-12-22 | Avax Technologies Inc. | Cryopreservation of haptenized tumor cells |
| US11214603B2 (en) | 2016-04-27 | 2022-01-04 | The Regents Of The University Of Michigan | C3D cellular and acellular vaccines for the prevention and treatment of cancer |
| CN115137814A (zh) * | 2022-07-01 | 2022-10-04 | 可蓝赛生物医药(上海)有限公司 | 一种肿瘤疫苗佐剂 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4086134A (en) * | 1973-09-18 | 1978-04-25 | University Of Glasgow | Method for preparation of vaccine against feline leukemia |
| BR9609026A (pt) * | 1995-06-07 | 1999-07-06 | Univ Jefferson | Composição processo para o tratamento do cáncer e de detecção para a produção de citicina por tumores para determinar a eficácia de um autólogo e kit diagnóstico para detecção para eficácia de compostos celulares autólogos |
-
1999
- 1999-02-17 PL PL99342856A patent/PL342856A1/xx not_active Application Discontinuation
- 1999-02-17 AU AU26869/99A patent/AU2686999A/en not_active Abandoned
- 1999-02-17 EP EP99907137A patent/EP1054690A2/en not_active Withdrawn
- 1999-02-17 IL IL13779199A patent/IL137791A0/xx unknown
- 1999-02-17 ZA ZA9901245A patent/ZA991245B/xx unknown
- 1999-02-17 KR KR1020007009049A patent/KR20010041018A/ko not_active Application Discontinuation
- 1999-02-17 JP JP2000531176A patent/JP2002502880A/ja not_active Withdrawn
- 1999-02-17 CA CA002320969A patent/CA2320969A1/en not_active Abandoned
- 1999-02-17 CN CN99803065A patent/CN1291105A/zh active Pending
- 1999-02-17 WO PCT/US1999/003536 patent/WO1999040925A2/en not_active Application Discontinuation
- 1999-02-17 BR BR9907912-7A patent/BR9907912A/pt not_active Application Discontinuation
- 1999-02-23 AR ARP990100710A patent/AR015237A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2686999A (en) | 1999-08-30 |
| EP1054690A2 (en) | 2000-11-29 |
| ZA991245B (en) | 1999-08-18 |
| CN1291105A (zh) | 2001-04-11 |
| KR20010041018A (ko) | 2001-05-15 |
| IL137791A0 (en) | 2001-10-31 |
| CA2320969A1 (en) | 1999-08-19 |
| WO1999040925A3 (en) | 1999-10-21 |
| JP2002502880A (ja) | 2002-01-29 |
| PL342856A1 (en) | 2001-07-16 |
| AR015237A1 (es) | 2001-04-18 |
| WO1999040925A2 (en) | 1999-08-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9307104A (pt) | Preparações reforçadora de mecanismos de defesa de hospedeiros e migrante com pico único b-glicano hidrossolúvel métodos para produzir uma preparação reforçadora de meanismos de defesa de hospedeiros para impedir infecção em um mamífero para estimular o reparo e cura de uma ferida e para estimular a proliferação de plaquetas composição farmacêutica e método para tratar infecção em mamíferos | |
| CN109431873B (zh) | 一种修复舒缓皮肤炎症的组合物 | |
| KR101098581B1 (ko) | Ａｂｈ 항원을 이용한 염증질환 개선용 조성물 | |
| Xia et al. | Nutritional and medicinal value | |
| Kim et al. | Beneficial effects on skin health using polysaccharides from red ginseng by‐product | |
| BR9910187A (pt) | Processo e composição para induzir uma resposta anti-tumor em um paciente mamìfero sofrendo de um tumor | |
| Mandal-Ghosh et al. | Neem leaf preparation enhances Th1 type immune response and anti-tumor immunity against breast tumor associated antigen | |
| BR9907912A (pt) | Composição, processos para tratar câncer, para eliciar linfócitos t que se infiltram em um tumor de um mamìfero, para eliciar uma resposta de hipersensibilidade do tipo retardo a um tumor de um mamìfero, e para preparar membranas de células tumorais modificadas com hapteno, e, membrana isolada de célula tumoral de mamìfero | |
| Zhou et al. | β-Nicotinamide mononucleotide (NMN) administrated by intraperitoneal injection mediates protection against UVB-induced skin damage in mice | |
| Ekambaram et al. | Hydrolysable tannin-rich fraction from Terminalia chebula Retz. fruits ameliorates collagen-induced arthritis in BALB/c mice | |
| BR0015597A (pt) | Uso de anticorpos como vacinas | |
| CN103892269A (zh) | 黑枸杞防晒美白片 | |
| EP2341916A1 (en) | Colostrum composition | |
| AU2013380577B2 (en) | Camelid compound(s), composition(s) and method(s) | |
| JPS6219525A (ja) | 植物起源の生物活性物質の製造法および同物質含有組成物 | |
| KR102289551B1 (ko) | 복합 히아루론산을 함유하는 화장료용 조성물 | |
| WO2011039629A2 (es) | Fracción bioactiva de petiveria alliacea, composición farmacéutica que la contiene y combinación con agentes inmunoestimulantes para el tratamiento del cáncer | |
| Guo et al. | Alleviation of ultraviolet‐B radiation‐induced photoaging using saussurea medusa maxim polysaccharide | |
| CN107737032B (zh) | 针对皮肤皲裂的药用护肤品 | |
| EP3568131B1 (en) | Composition comprising 7-hydroxymatairesinol for use in the treatment and in the prevention of trichological diseases of inflammatory and/or hormonal origin | |
| Pielok et al. | Betulin–application in dermatology and cosmetology | |
| Gren | Effects of Iscador preparations on the reactivity of mouse immune system | |
| BR9815983A (pt) | Processos para tratar câncer selecionado dentre o grupo consistindo de adencarcinoma e leucemia, para eliciar linfócitos t para infiltra um tumor de um humano, para eliciar uma resposta imune inflamatória a um tumor de um humano, para eliciar uma resposta de hipersensibilidade de tipo retardado a um tumor de um humano, e, composição para o tratamento de câncer | |
| Aaronson et al. | Inhibition by soluble ribonucleic acid of stimulatory effect of liver template ribonucleic acid | |
| Laude et al. | Isoprinosine trial in herpes zoster. Effects on delayed cutaneous hypersensitivity |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA10 | Dismissal: dismissal - article 33 of industrial property law | ||
| B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |